Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis NATCOPHARM

Max Ratio

0.99

Dividend Yield

0.86 %

5Y Dividend Growth

-18.00 %

Consecutive Years

5Y Average Payout Ratio

29.57 %

Dividend History NATCOPHARM

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 0.86 %
Consecutive Years 0
Forward Annual Dividend 8.00 INR
Consistent Years 0
Dividend CAGR 3Y 18.00 %
Continuous Dividends
Dividend CAGR 5Y -3.86 %
Payout Ratio TTM 1.94 %
Dividend CAGR 10Y 19.12 %
Ex Dividend Date 08/19/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth NATCOPHARM

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin NATCOPHARM

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income NATCOPHARM

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM NATCOPHARM

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio NATCOPHARM

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Natco Pharma Limited NATCOPHARM

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself NATCOPHARM

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 11.05
Forward PE 16.86
Enterprise Value Revenue 2.96
Price Sales TTM 3.87
Enterprise Value EBITDA 6.05
Price Book MRQ 1.94

Natco Pharma Limited Dividends: 0.54 % Yield, History, Payment Schedule

NATCOPHARM
Current price
933.60 INR -11.41 INR (-1.21%)
Last closed 949.25 INR
ISIN INE987B01026
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange National Stock Exchange of India
Capitalization 170 033 826 802 INR
Yield for 12 month -35.61 %
1Y
3Y
5Y
10Y
15Y
NATCOPHARM
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+44 322 592 535 INR

Last Year

+40 023 244 077 INR

Current Quarter

+13 631 104 877 INR

Last Quarter

+13 290 077 194 INR

Current Year

+37 048 002 878 INR

Last Year

+32 535 637 117 INR

Current Quarter

+11 933 967 316 INR

Last Quarter

+10 959 888 322 INR
EBITDA 16 854 366 340 INR
Operating Margin TTM 38.65 %
Price to Earnings 11.05
Return On Assets TTM 9.96 %
PEG Ratio
Return On Equity TTM 19.44 %
Wall Street Target Price 88 618.10 INR
Revenue TTM 43 904 560 389 INR
Book Value 482.92 INR
Revenue Per Share TTM
Dividend Share 5.00 INR
Quarterly Revenue Growth YOY -0.60 %
Dividend Yield 0.86 %
Gross Profit TTM 36 180 934 547 INR
Earnings per share 85.88 INR
Diluted Eps TTM 85.88 INR
Most Recent Quarter III 2025
Quarterly Earnings Growth YOY -23.50 %
Profit Margin 35.05 %

Technical Indicators NATCOPHARM

For 52 Weeks

725.20 INR 1 499.13 INR
50 Day MA 835.66 INR
Shares Short Prior Month
200 Day MA 862.90 INR
Short Ratio
Shares Short
Short Percent